BE896572A - Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique - Google Patents

Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique

Info

Publication number
BE896572A
BE896572A BE0/210633A BE210633A BE896572A BE 896572 A BE896572 A BE 896572A BE 0/210633 A BE0/210633 A BE 0/210633A BE 210633 A BE210633 A BE 210633A BE 896572 A BE896572 A BE 896572A
Authority
BE
Belgium
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
therapeutics
preparation
Prior art date
Application number
BE0/210633A
Other languages
English (en)
French (fr)
Inventor
C Malen
J-L Peglion
J Duhault
M Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BE896572A publication Critical patent/BE896572A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE0/210633A 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique BE896572A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
BE896572A true BE896572A (fr) 1983-10-26

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210633A BE896572A (fr) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique

Country Status (22)

Country Link
JP (1) JPS5910584A (cg-RX-API-DMAC7.html)
KR (1) KR840004428A (cg-RX-API-DMAC7.html)
AT (1) ATA125383A (cg-RX-API-DMAC7.html)
AU (1) AU1395383A (cg-RX-API-DMAC7.html)
BE (1) BE896572A (cg-RX-API-DMAC7.html)
DD (1) DD209833A5 (cg-RX-API-DMAC7.html)
DE (1) DE3315106A1 (cg-RX-API-DMAC7.html)
DK (1) DK183583A (cg-RX-API-DMAC7.html)
ES (1) ES521895A0 (cg-RX-API-DMAC7.html)
FR (1) FR2525603A1 (cg-RX-API-DMAC7.html)
GB (1) GB2133401B (cg-RX-API-DMAC7.html)
GR (1) GR78481B (cg-RX-API-DMAC7.html)
IL (1) IL68497A0 (cg-RX-API-DMAC7.html)
IT (1) IT1167123B (cg-RX-API-DMAC7.html)
LU (1) LU84770A1 (cg-RX-API-DMAC7.html)
MA (1) MA19783A1 (cg-RX-API-DMAC7.html)
NL (1) NL8301476A (cg-RX-API-DMAC7.html)
NO (1) NO831473L (cg-RX-API-DMAC7.html)
OA (1) OA07412A (cg-RX-API-DMAC7.html)
PT (1) PT76595B (cg-RX-API-DMAC7.html)
SE (1) SE8302347L (cg-RX-API-DMAC7.html)
ZA (1) ZA832927B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EA016558B1 (ru) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
US8168624B2 (en) 2004-12-21 2012-05-01 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
EP2111859A1 (en) 2004-12-23 2009-10-28 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
WO2008070111A2 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
KR20180094131A (ko) 2010-09-01 2018-08-22 에자이 알앤드디 매니지먼트 가부시키가이샤 신장 손상을 갖는 개체에 대한 로카세린의 투여
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
GB8311508D0 (en) 1983-06-02
DE3315106A1 (de) 1983-11-03
GB2133401A (en) 1984-07-25
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
FR2525603A1 (fr) 1983-10-28
FR2525603B1 (cg-RX-API-DMAC7.html) 1984-09-14
DK183583D0 (da) 1983-04-26
NL8301476A (nl) 1983-11-16
SE8302347L (sv) 1983-10-28
GB2133401B (en) 1985-10-23
ATA125383A (de) 1986-05-15
NO831473L (no) 1983-10-28
ZA832927B (en) 1984-06-27
ES8405796A1 (es) 1984-06-16
OA07412A (fr) 1984-11-30
IT8348155A0 (it) 1983-04-26
MA19783A1 (fr) 1983-12-31
IL68497A0 (en) 1983-07-31
DK183583A (da) 1983-10-28
LU84770A1 (fr) 1984-11-28
KR840004428A (ko) 1984-10-15
JPS5910584A (ja) 1984-01-20
GR78481B (cg-RX-API-DMAC7.html) 1984-09-27
ES521895A0 (es) 1984-06-16
DD209833A5 (de) 1984-05-23
PT76595B (fr) 1986-01-21
AU1395383A (en) 1983-11-03
IT1167123B (it) 1987-05-13

Similar Documents

Publication Publication Date Title
MA19845A1 (fr) Nouvelles piperidinamines et leur preparation
ES502384A0 (es) Perfeccionamientos en aparatos para abarcar y elaborar sena-les electricas
SG3489G (en) Improvements in and relating to cutlery
BR1100036A (pt) Composto e composição farmacêutica
BE888864A (fr) Substances anticoagulantes et leur preparation
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
BE896572A (fr) Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique
ES534446A0 (es) Perfeccionamientos en fonocardiografos y electrocardiografos
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
FR2606410B1 (fr) Imidazopyridines, leur preparation et leur application en therapeutique
FR2553777B1 (fr) Nouveaux complexes de platine et leur application en therapeutique
DE3378954D1 (en) Perfluorocarbon emulsions and their preparation and use in therapy
BE896018A (fr) Amides pyrrolacetiques, leur preparation et leur utilisation
IT1194436B (it) Metodo per formare ondulazione permanenti nei capelli
FR2543140B1 (fr) Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BR8801757A (pt) Composicao em particulas
GB2122875B (en) Improvements in and relating to cutlery
FR2352804A1 (fr) 4-quinazolinyl-guanidines, leur preparation et leur application en therapeutique
FR2542744B2 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
ZA834344B (en) Use of 1,4-dihydropyridines in antiarteriosclerotic agents and their preparation
FR2542745B1 (fr) Polysaccharide, sa preparation et son application en therapeutique
FR2544308B1 (fr) Ethines substituees, leur preparation et leur application en therapeutique
BE856637A (fr) Nouvelles 7-b-oxyiminoacylcephalosporines et leur application en therapeutique
BE875588A (fr) Esters benzylideniques et leur application en therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ADIR

Effective date: 19860430